Mechanistically, siRNA silencing of HMGB1 (Figure 3F) abolished PRKN IFN gene expression in human (PC3) and murine (TRAMP-C2) tumor cell types (Figure 3G). The gene discussed is IFNA1; the disease is neoplasm.